Potassium-retaining diuretics and incident Alzheimer disease [4]

Archives of Neurology

Volumn 63, Issue 10, 2006, Pages 1507-

  Reyes, Ariel J ^a  

^a Institute of Cardiovascular Theory Montevideo   (Uruguay)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; DIURETIC AGENT; EPLERENONE; LOOP DIURETIC AGENT; NATRIURETIC FACTOR; POTASSIUM; SODIUM CHANNEL BLOCKING AGENT; SPIRONOLACTONE;

ALZHEIMER DISEASE; DRUG ACTIVITY; FLUID RETENTION; HUMAN; INCIDENCE; LETTER; METABOLIC ACTIVATION; OXIDATIVE STRESS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RISK FACTOR;

EID: 33749608425     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.10.1507-b     Document Type: Letter

References (4)

1. Khachaturian AS, Zandi PP, Lyketsos CG, et al. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006;63:686-692.
2. Reyes AJ, Leary WP, Crippa G, Maranhão MFC, Hernández- Hernández R. The aldosterone antagonist and facultative diuretic eplerenone: a critical review. Eur J Intern Med. 2005;16:3-11.
3. Reyes AJ. Cardiovascular drugs and serum uric acid. Cardiovasc Drugs Ther. 2003;17:397-414.
4. Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L. Heart failure risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med2006;166:1003-1008.